Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-10

Clinical Trial Update: Epidemiologic Study Of Diabetes And Cancer Risk

View source ↗

Summary

Takeda-sponsored epidemiologic study completed, examining the relationship between type 2 diabetes mellitus and cancer risk, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2, Cancer | Status: COMPLETED | Results posted: 2017-03-10